Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

28 May 2026

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

73690 result(s) found, displaying 66101 to 66125

ABILIFY ODT aripiprazole 30mg orally disintegrating tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Otsuka Australia Pharmaceutical Pty Ltd
ARBEELA BREEZHALER indacaterol maleate 150 microgram hard capsule for inhalation Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ARBEELA BREEZHALER indacaterol maleate 300 microgram hard capsule for inhalation Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ELIGLUSTAT GENZYME eliglustat (as tartrate) 84 mg capsule blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
ENBREL etanercept (rch) 50mg powder for injection vial and diluent syringe composite pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
FAMGEN famciclovir 125mg tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
FAMGEN famciclovir 250mg tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
FAMGEN famciclovir 500mg tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
Guerbet Australia Pty Ltd - Optistar LE Mulitpack - Unclassified Cancelled under s41GL(d) of the Act

22 December 2016

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
Guerbet Australia Pty Ltd Unclassified Cancelled under s41GL(d) of the Act

22 December 2016

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
IMMUCYST BCG 6.6 - 19.2 x 100000000 CFU powder for injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
Medela Australia Pty Ltd - Trolley, medical devices Cancelled under s41GL(d) of the Act

22 December 2016

Cancellation by sponsor

Requested by Medela Australia Pty Ltd
MERIOSTA zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
MERIOSTA zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
OSTAZOL zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
OSTAZOL zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
SCHERING-PLOUGH TESTOSTERONE testosterone 100mg implant tube Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
SCHERING-PLOUGH TESTOSTERONE testosterone 200mg implant tube Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
TOVANOR BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
XOTERNA BREEZHALER 110/50 indacaterol (as maleate)/ glycopyrronium (as bromide) 110 microgram / 50 microgram powder for inhalation in hard capsule Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ZOLEDRONIC SANDOZ zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ZOLEDRONIC SANDOZ zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ALBALON RELIEF phenylephrine hydrochloride 1.2mg/mL single dose eye drops solution ampoule Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
APO-OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil 20 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil 40 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Apotex Pty Ltd

Last updated

28 May 2026

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

ABILIFY ODT aripiprazole 30mg orally disintegrating tablet blister pack Cancelled under s30(1)(c)

ARBEELA BREEZHALER indacaterol maleate 150 microgram hard capsule for inhalation Cancelled under s30(1)(c)

ARBEELA BREEZHALER indacaterol maleate 300 microgram hard capsule for inhalation Cancelled under s30(1)(c)

ELIGLUSTAT GENZYME eliglustat (as tartrate) 84 mg capsule blister pack Cancelled under s30(1)(c)

ENBREL etanercept (rch) 50mg powder for injection vial and diluent syringe composite pack Cancelled under s30(1)(c)

FAMGEN famciclovir 125mg tablet blister pack Cancelled under s30(1)(c)

FAMGEN famciclovir 250mg tablet blister pack Cancelled under s30(1)(c)

FAMGEN famciclovir 500mg tablet blister pack Cancelled under s30(1)(c)

Guerbet Australia Pty Ltd - Optistar LE Mulitpack - Unclassified Cancelled under s41GL(d) of the Act

Guerbet Australia Pty Ltd Unclassified Cancelled under s41GL(d) of the Act

IMMUCYST BCG 6.6 - 19.2 x 100000000 CFU powder for injection vial Cancelled under s30(1)(c)

Medela Australia Pty Ltd - Trolley, medical devices Cancelled under s41GL(d) of the Act

MERIOSTA zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

MERIOSTA zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

OSTAZOL zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

OSTAZOL zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

SCHERING-PLOUGH TESTOSTERONE testosterone 100mg implant tube Cancelled under s30(1)(c)

SCHERING-PLOUGH TESTOSTERONE testosterone 200mg implant tube Cancelled under s30(1)(c)

TOVANOR BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister Cancelled under s30(1)(c)

XOTERNA BREEZHALER 110/50 indacaterol (as maleate)/ glycopyrronium (as bromide) 110 microgram / 50 microgram powder for inhalation in hard capsule Cancelled under s30(1)(c)

ZOLEDRONIC SANDOZ zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

ZOLEDRONIC SANDOZ zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

ALBALON RELIEF phenylephrine hydrochloride 1.2mg/mL single dose eye drops solution ampoule Cancelled under s30(1)(c)

APO-OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil 20 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

APO-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil 40 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect